Use of Selegiline as Monotherapy and in Combination with Levodopa in the Management of Parkinson's Disease: Perspectives from the MONOCOMB Study

Category Primary study
JournalProgress in Neurotherapeutics and Neuropsychopharmacology
Year 2008
Loading references information
This article has no abstract
Epistemonikos ID: 1cbbdaf4599832867f7cfe77f49470d9db88b918
First added on: Sep 25, 2017